Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.

Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, Singer DE.

N Engl J Med. 2003 Sep 11;349(11):1019-26.

2.

Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal.

Odén A, Fahlén M, Hart RG.

Thromb Res. 2006;117(5):493-9. Epub 2004 Dec 25. Review.

PMID:
16517250
3.

Guidelines for stroke prevention in patients with atrial fibrillation.

Howard PA.

Drugs. 1999 Dec;58(6):997-1009. Review.

PMID:
10651387
4.
5.

Warfarin therapy for an octogenarian who has atrial fibrillation.

Gage BF, Fihn SD, White RH.

Ann Intern Med. 2001 Mar 20;134(6):465-74. Review.

PMID:
11255522
6.

[Atrial fibrillation and thromboembolic events prevention. State of the art].

Matteoli S, Trappolini M, Chillotti FM.

Minerva Cardioangiol. 2001 Feb;49(1):1-13. Review. Italian.

PMID:
11279381
7.

Antithrombotic therapies for stroke prevention in atrial fibrillation.

Economides Muñoz C, Singh BN.

Minerva Cardioangiol. 2004 Apr;52(2):125-39. Review.

8.

Anticoagulation for atrial fibrillation in the elderly.

Halperin JL.

Am J Geriatr Cardiol. 2005 Mar-Apr;14(2):81-6. Review.

PMID:
15785149
9.

Prevention of thromboembolic events in atrial fibrillation.

Koefoed BG, Gulløv AL, Petersen P.

Thromb Haemost. 1997 Jul;78(1):377-81. Review.

PMID:
9198182
10.

Lessons from the Stroke Prevention in Atrial Fibrillation trials.

Hart RG, Halperin JL, Pearce LA, Anderson DC, Kronmal RA, McBride R, Nasco E, Sherman DG, Talbert RL, Marler JR; Stroke Prevention in Atrial Fibrillation Investigators..

Ann Intern Med. 2003 May 20;138(10):831-8. Review.

PMID:
12755555
11.

Anticoagulation and atrial fibrillation.

Atwood JE, Albers GW.

Herz. 1993 Feb;18(1):27-38. Review.

PMID:
8454250
12.

Novel oral anticoagulants in atrial fibrillation: a meta-analysis of large, randomized, controlled trials vs warfarin.

Dogliotti A, Paolasso E, Giugliano RP.

Clin Cardiol. 2013 Feb;36(2):61-7. doi: 10.1002/clc.22081. Epub 2013 Jan 21. Review.

13.

Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis.

Agarwal S, Hachamovitch R, Menon V.

Arch Intern Med. 2012 Apr 23;172(8):623-31; discussion 631-3. doi: 10.1001/archinternmed.2012.121. Epub 2012 Mar 26. Review.

PMID:
22450212
14.

Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis.

Reynolds MW, Fahrbach K, Hauch O, Wygant G, Estok R, Cella C, Nalysnyk L.

Chest. 2004 Dec;126(6):1938-45. Review.

PMID:
15596696
15.

Management of nonvalvular atrial fibrillation: a comprehensive approach.

Iuliano L, Di Matteo A, Straface G.

Indian J Med Sci. 2009 Sep;63(9):419-30. doi: 10.4103/0019-5359.56111. Review.

16.

Atrial fibrillation and stroke management: present and future.

Holmes DR.

Semin Neurol. 2010 Nov;30(5):528-36. doi: 10.1055/s-0030-1268861. Epub 2011 Jan 4. Review.

PMID:
21207345
17.

Dabigatran and atrial fibrillation: the alternative to warfarin for selected patients.

[No authors listed]

Prescrire Int. 2012 Feb;21(124):33-6. Review.

PMID:
22413715
18.

New-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugs.

Garcia DA, Lopes RD, Hylek EM.

Thromb Haemost. 2010 Dec;104(6):1099-105. doi: 10.1160/TH10-07-0491. Epub 2010 Sep 30. Review.

PMID:
20886196
19.

Apixaban for the prevention of stroke in atrial fibrillation.

Littrell R, Flaker G.

Expert Rev Cardiovasc Ther. 2012 Feb;10(2):143-9. doi: 10.1586/erc.11.187. Review.

PMID:
22292869
20.

Aspirin in stroke prevention in nonvalvular atrial fibrillation and stable vascular disease: an era of new anticoagulants.

Turagam MK, Velagapudi P, Leal MA, Kocheril AG.

Expert Rev Cardiovasc Ther. 2012 Apr;10(4):433-9. doi: 10.1586/erc.12.19. Review.

PMID:
22458577

Supplemental Content

Support Center